دورية أكاديمية
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients
| العنوان: | First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients |
|---|---|
| المؤلفون: | O’Byrne, K.J., Lee, K.H., Kim, S.-W., Park, K., Nishio, M., Sakai, H., Ohe, Y., Fukuhara, T., Kang, J.-H., Daga, H., Yu, C.-J., Hotta, K., Tanaka, H., Takeda, M., Yokoyama, T., Nathan, F.E., Lee, J.-S. |
| المصدر: | In ESMO Open February 2022 7(1) |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 20597029 |
|---|---|
| DOI: | 10.1016/j.esmoop.2022.100394 |